Matinas BioPharma Holdings (MTNB) Selling, General & Administrative (2013 - 2026)
Matinas BioPharma Holdings' Selling, General & Administrative was $1.56 million in Q2 2026, down 15.4% from $1.84 million a year earlier and down 19.7% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Matinas BioPharma Holdings' Selling, General & Administrative was $6.67 million through Jun 30, 2026, down 11.1% year-over-year; for FY2025, it came in at $6.88 million, down 21.2% from FY2024.
- Selling, General & Administrative has now declined for three consecutive years, with a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $8.73 million in FY2024 (-15.8%), $10.37 million in FY2023 (-6.5%), $11.1 million in FY2022 (+9.0%) and $10.19 million in FY2021 (+1.8%).
- The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative since Q3 2017.
- Compared with a year earlier, Selling, General & Administrative was higher in 1 of the last eight quarters, with an average decline of 17.6%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2022 (growth of 24.9%); the worst was Q3 2025 (a decline of 26.4%).
- Per Business Quant data, MTNB's Selling, General & Administrative in the three quarters before Q2 2026 was $1.94 million (Q1 2026), $1.6 million (Q4 2025) and $1.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Matinas BioPharma Holdings | 15.63 Mn | 3.04 Mn | - | 1.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Mn |
| Mar 31, 2026 | 1.94 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 2.84 Mn |
| Jun 30, 2023 | 2.60 Mn |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 2.82 Mn |
| Jun 30, 2022 | 2.86 Mn |
| Mar 31, 2022 | 2.74 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 2.26 Mn |
API Access
Matinas BioPharma Holdings Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();